Related Experiment Videos
Myocardial revascularization in a hemophiliac
C Nahas1, J W Jones, A C Beall
1Cora and Webb Mading Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.
Cardiovascular Surgery (London, England)
|August 1, 1996
Summary
A mild hemophiliac patient safely underwent myocardial revascularization surgery while receiving factor VIIIC. This demonstrates successful management of bleeding disorders during major cardiac procedures.
Area of Science:
- Cardiology
- Hematology
Background:
- Myocardial revascularization is a critical cardiac surgery.
- Hemophilia A is a genetic bleeding disorder requiring careful management.
Observation:
- A patient with mild hemophilia A underwent myocardial revascularization.
- The patient received factor VIIIC concentrate for perioperative management.
Findings:
- The myocardial revascularization procedure was successful.
- The patient experienced no complications related to bleeding or factor replacement.
Implications:
- This case highlights the safety and efficacy of factor VIIIC in managing mild hemophilia A patients undergoing major cardiovascular surgery.
- It supports the feasibility of performing complex cardiac procedures in patients with inherited bleeding disorders with appropriate hemostatic support.